Changeflow GovPing Pharma & Drug Safety Ionizable Lipidoid Compositions and Therapeutic...
Routine Notice Added Final

Ionizable Lipidoid Compositions and Therapeutic Uses Thereof

Favicon for changeflow.com USPTO Patent Applications - Organic Chemistry (C07D)
Published
Detected
Email

Summary

Ionizable Lipidoid Compounds for Therapeutic Agent Delivery

What changed

The USPTO published patent application US20260098014A1 covering ionizable lipidoid compounds of formula (I) and nanoparticle compositions for delivering therapeutic agents. The application includes pharmaceutical compositions comprising these lipidoid delivery systems.

Pharmaceutical and biotechnology companies developing drug delivery technologies should review this patent application for potential freedom-to-operate considerations. The broad claims to lipidoid-based therapeutic delivery systems may affect product development strategies for lipid nanoparticle and nucleic acid delivery platforms.

What to do next

  1. Monitor for updates

Archived snapshot

Apr 9, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

IONIZABLE LIPIDOID COMPOSITIONS AND THERAPEUTIC USES THEREOF

Application US20260098014A1 Kind: A1 Apr 09, 2026

Inventors

Srinivas Abbina, Chelsea RamEl Martinez, Vandan Paresh Jakharia, Timothy Ray Blake, Ulugbek Barotov

Abstract

Disclosed are lipidoid compounds having the structure of formula (I): or a salt thereof, wherein the groups are as defined in the application. Also disclosed are nanoparticle compositions comprising a lipidoid of the invention that are capable of delivering a therapeutic agent. The application also discloses pharmaceutical compositions comprising a lipidoid composition of the invention.

CPC Classifications

C07D 233/36 A61K 9/5123 A61K 48/0041 C07C 229/24 C07D 205/04 C07D 207/09 C07D 211/26 C07D 233/61 C07D 239/10 C07D 295/13 C07D 317/38 C07F 9/65742 C07C 2601/08

Filing Date

2025-10-08

Application No.

19352724

View original document →

Get daily alerts for USPTO Patent Applications - Organic Chemistry (C07D)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 9th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260098014A1

Who this affects

Applies to
Pharmaceutical companies Medical device makers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent examination IP licensing
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Medical Devices

Get alerts for this source

We'll email you when USPTO Patent Applications - Organic Chemistry (C07D) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!